46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.34.B - Wholesale trade of non-alcoholic beverages
46.45.Z - Wholesale trade of perfumes and cosmetics
56.10.A - Food service activities
64.92.Z - Other forms of credit granting
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 7 | 2,8 | 11,1 | 297 |
EBITDA | 13,8 | 17,5 | 42 | 140 |
Short time liabilities | 370,5 | 360,4 | 391,6 | 8,7 |
Equity capital | 94,9 | 85,3 | 92 | 7,8 |
Operating profit (EBIT) | 9 | 12,6 | 37,2 | 194,6 |
Assets | 500,6 | 524,2 | 584,1 | 11,4 |
Net profit (loss) | 8,2 | 2,1 | 6,7 | 218,6 |
Cash | 4 | 4 | 3,9 | -2,4 |
Liabilities and provisions for liabilities | 405,7 | 438,9 | 492,1 | 12,1 |
Net income from sale | 1526,3 | 1668,1 | 1792,7 | 7,5 |
Working assets | 354,2 | 377,8 | 440,3 | 16,5 |
Depreciation | 4,8 | 4,9 | 4,8 | -1,1 |
% | % | % | p.p. | |
Profitability of capital | 8,7 | 2,5 | 7,3 | 4,8 |
Equity capital to total assets | 19 | 16,3 | 15,8 | -0,5 |
Gross profit margin | 0,5 | 0,2 | 0,6 | 0,4 |
EBITDA Margin | 0,9 | 1,1 | 2,3 | 1,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 89 | 79 | 80 | 1 |
Current financial liquidity indicator | ||||
Net dept to EBITDA | 8.556634902954102 | 2,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane